Patient-relevant outcomes sit at the heart of the EU HTA reforms, but ensuring they reflect lived experience requires you to ...

Healthcare is changing rapidly, bringing unprecedented data and complex treatment pathways to the point of care. Clinical ...

A year after its initial launch as QuintilesIMS, the pharma service provider has re-launched as IQVIA. Its new name maintains parts of its original formation, with the ‘I’ representing IMS and the ‘Q’ ...

How does a healthcare system assess the value of innovation, whether in the form of new diagnostics, devices, medicines or other technology?

Johnson & Johnson (J&J) has announced that the National Institute for Health and Care Excellence (NICE) has published Final ...

When independent, evidence-based education directly connects with clinicians at the point of care, clinical practice changes. Driven by this vital mission, ...

Eli Lilly has entered into an agreement to acquire Dice Therapeutics for approximately $2.4bn, marking a significant boost to its immunology pipeline. The deal grants Lilly access to the biopharma’s ...

At eight years of follow-up, results showed that Tagrisso continued to show an OS benefit, reducing the risk of death ...

Inizio has appointed Oisín Ó Gógáin as Chief People Officer. Based at Inizio’s Dublin headquarters, Ó Gógáin joins from Aon, ...

Imfinzi is approved in the US, EU, Japan, China and many other countries around the world as the standard-of-care treatment ...

Roche’s Enspryng (satralizumab), a treatment for a rare autoimmune disease, has been given FDA Priority Review to a ...

Pfizer and BioNTech’s XFG-adapted COVID-19 vaccine has been approved by the US FDA, with the companies announcing the ...